hyaluronidase, ovine

FDA Drug Profile — VITRASE

Drug Details

Generic Name
hyaluronidase, ovine
Brand Names
VITRASE
Application Number
BLA021640
Sponsor
Bausch & Lomb Incorporated
NDC Codes
1
Dosage Forms
INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients
HYALURONIDASE (OVINE)

Indications and Usage

1 INDICATIONS AND USAGE VITRASE is an endoglycosidase indicated as an adjuvant: in subcutaneous fluid administration for achieving hydration. ( 1.1 ) for increasing the dispersion and absorption of other injected drugs. ( 1.2 ) for improving resorption of radiopaque agents, in subcutaneous urography. ( 1.3 ) 1.1 Subcutaneous Fluid Administration (Hypodermoclysis) VITRASE ® (hyaluronidase injection) is indicated as an adjuvant in subcutaneous fluid administration for achieving hydration. 1.2 Dispersion and Absorption of Injected Drugs VITRASE is indicated as an adjuvant to increase the dispersion and absorption of other injected drugs. 1.3 Subcutaneous Urography VITRASE is indicated as an adjuvant in subcutaneous urography for improving resorption of radiopaque agents.